## Abstract A study was conducted during a 1 year follow‐up to characterize the viral kinetics in hepatitis B e antigen (HBeAg)‐positive chronic hepatitis B and to develop a model of predicting the probability of spontaneous HBeAg seroconversion. Fifty‐seven patients with HBeAg‐positive chronic hep
High Rates of Viral Suppression After Long-term Entecavir Treatment of Asian Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B
✍ Scribed by Pan, Calvin Q.; Tong, Myron; Kowdley, Kris V.; Hu, Ke–Qin; Chang, Ting–Tsung; Lai, Ching–Lung; Yoon, Seung Kew; Lee, Samuel S.; Cohen, David; Tang, Hong
- Book ID
- 123100493
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 420 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1542-3565
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Treatment of 171 patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) with adefovir dipivoxil (ADV) 10 mg over 48 weeks resulted in significant histological, virological, serological, and biochemical improvement compared with placebo. The long-term efficacy and safety of AD
This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi
The objective of this study was to evaluate the role of hepatitis B virus (HBV) precore mutations in patients with anti-me-positive chronic hepatitis B with or without previous known HBe antigen (HBeAg) viremic phase, and to assess the potential implication of precore mutants in HBeAg-negative react